Monopar Therapeutics Inc. Common Stock (MNPR)
Stock · NASDAQ · Health Care
$69.43as of 10/16/2026
Price chart
Active signals
MNPR Signal Track Record
How signals performed across all stocks →What MNPR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 29 | +0.3% | 52% | October 6, 2026 |
| Bollinger Band Breakout | 23 | +0.8% | 52% | August 4, 2026 |
| Bollinger Band Breakdown | 20 | -2.5% | 40% | September 16, 2026 |
| 200-Day Moving Average TouchActive now | 9 | +1.3% | 56% | May 27, 2026 |
| Any 20-session window (baseline) | -2.8% | 45% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MNPR
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasmin…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 22
- Website
- www.monopartx.com/
Fundamentals
- 1-day range
- $70.05$73.28
- Market cap
- $805.29M
- P/E (trailing)
- —
- P/E (forward)
- -37.48
- EPS (trailing)
- $-2.17
- Dividend yield
- —
- Beta
- 1.54
- Avg. volume
- 207.0K
Forecasts
12 analyst ratings
Monopar Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MNPRMonopar Therapeutics Inc. Common Stock$69.27▼ 3.52%Market cap $805.29MP/E —$50.07$124.82
- CLYMClimb Bio Inc. Common Stock$9.82▼ 9.99%Market cap $801.68MP/E —$1.64$18.33
- DRUGBright Minds Biosciences Inc. Common Stock$51.3▼ 5.37%Market cap $792.81MP/E —$68.02$170
- KURAKura Oncology Inc. Common Stock$9.08▼ 6.39%Market cap $823.83MP/E —$7.36$13.9
- PHARPharming Group N.V. ADS each representing 10 ordinary shares$9.36▼ 2.80%Market cap $766.28MP/E 73.41$0.8338$1.82
- ACRSAclaris Therapeutics Inc. Common Stock$3.28▼ 6.02%Market cap $850.55MP/E —$1.74$6.6
- DSGNDesign Therapeutics Inc. Common Stock$10.31▼ 1.62%Market cap $861.75MP/E —$5.28$17.25
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MNPR Monopar Therapeutics Inc. Common Stock | $805.29M | — | $69.27 | ▼ 3.52% | $50.07$124.82 |
| CLYM Climb Bio Inc. Common Stock | $801.68M | — | $9.82 | ▼ 9.99% | $1.64$18.33 |
| DRUG Bright Minds Biosciences Inc. Common Stock | $792.81M | — | $51.3 | ▼ 5.37% | $68.02$170 |
| KURA Kura Oncology Inc. Common Stock | $823.83M | — | $9.08 | ▼ 6.39% | $7.36$13.9 |
| PHAR Pharming Group N.V. ADS each representing 10 ordinary shares | $766.28M | 73.41 | $9.36 | ▼ 2.80% | $0.8338$1.82 |
| ACRS Aclaris Therapeutics Inc. Common Stock | $850.55M | — | $3.28 | ▼ 6.02% | $1.74$6.6 |
| DSGN Design Therapeutics Inc. Common Stock | $861.75M | — | $10.31 | ▼ 1.62% | $5.28$17.25 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Christopher M. Starr · October 1, 2026 · Option Exercise8.4K @ $0.005
- Christopher M. Starr · October 1, 2026 · Sale799 @ $79.67
- Christopher M. Starr · October 1, 2026 · Sale3.0K @ $78.82
- Christopher M. Starr · October 1, 2026 · Sale4.6K @ $78.09
- Andrew Cittadine · September 30, 2026 · Option Exercise4.4K
- Andrew Cittadine · September 30, 2026 · Tax Withholding1.9K @ $79.67
- Chandler Robinson · September 30, 2026 · Option Exercise9.8K
- Chandler Robinson · September 30, 2026 · Tax Withholding4.3K @ $79.67
- Quan Anh Vu · September 30, 2026 · Option Exercise614
- Quan Anh Vu · September 30, 2026 · Tax Withholding180 @ $79.67
- Chandler Robinson · September 24, 2026 · Option Exercise15.0K @ $14
- Chandler Robinson · September 24, 2026 · Option Exercise14.1K @ $30
- Chandler Robinson · September 24, 2026 · Sale600 @ $89.79
- Chandler Robinson · September 24, 2026 · Sale8.4K @ $88.97
- Chandler Robinson · September 24, 2026 · Sale9.6K @ $87.96
Institutional Ownership
March 31, 2026
- Total shares held
- 6.16M
- Total value held
- $334.61M
- Institutional holders
- 77
- Unknown1.32M
- Unknown667.2K
- Unknown345.6K
- Unknown323.7K
- Unknown316.6K
- Unknown309.2K
- Unknown270.1K
- Unknown264.3K
- Unknown226.5K
- Unknown218.5K
See the full, filterable feed with live charts on the MarketWall dashboard.